Moreover, Sheean and colleagues showed that obese women with estrogen receptor-positive metastatic breast cancer had significantly higher levels of abdominal obesity and serum biomarkers of inflammation, with a lower quality of life compared to women without obesity [37]. Here, ESR1 is linked to obesity due to melanocortin 4 receptor deficiency.